Clinical Trial Update: Kronos Early Estrogen Prevention Study (KEEPS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the Kronos Early Estrogen Prevention Study (KEEPS) with status listed as UNKNOWN; the trial concerns menopause and atheroscler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Menopause

Drugs mentioned

• ESTRADIOL (Estradiol)
• PREMARIN (Conjugated estrogens)

Snippet

Sponsor: Kronos Longevity Research Institute | Conditions: Menopause, Arteriosclerosis | Phase 4 | Status: UNKNOWN